Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.
暂无分享,去创建一个
J. Gris | H. Décousus | P. Mismetti | Patrick Mismetti | C. Chauleur | Celine Chauleur | Jean Christophe Gris | Sylvie Laporte | Florence Rancon | Marie-Noëlle Varlet | Herve Decousus | M. Varlet | S. Laporte | F. Rancon
[1] C. Jégo,et al. Low Molecular Weight Heparins , 2012, Drugs.
[2] P. Godeau. Conférence de consensus , 2000 .
[3] B. Yawn,et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. , 2001, American journal of obstetrics and gynecology.
[4] I. Greer,et al. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy , 1999, British journal of obstetrics and gynaecology.
[5] M Greaves,et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.
[6] L. Salmi,et al. [Consensus methods: review of original methods and their main alternatives used in public health]. , 2008 .
[7] D. Hunter,et al. Qualitative Research: Consensus methods for medical and health services research , 1995 .
[8] B. Brenner,et al. Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review , 1999, Thrombosis and Haemostasis.
[9] R. Zotz,et al. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium , 2003, Thrombosis and Haemostasis.
[10] P. Sandset,et al. Ante‐ and postnatal risk factors of venous thrombosis: a hospital‐based case–control study , 2008, Journal of thrombosis and haemostasis : JTH.
[11] J. Kujovich. Thrombophilia and pregnancy complications. , 2004, American journal of obstetrics and gynecology.
[12] Glenn Regehr,et al. Delphi as a method to establish consensus for diagnostic criteria. , 2003, Journal of clinical epidemiology.
[13] M. Stephenson,et al. Low‐Molecular‐Weight Heparins in Pregnancy , 1999, Pharmacotherapy.
[14] G. Leone,et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis , 2006 .
[15] E. Myers,et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. , 2006, American journal of obstetrics and gynecology.
[16] C. Négrier,et al. Management of pregnant women with increased risk of venous thrombosis , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[17] Louis-Rachid Salmi,et al. Méthodes de consensus : revue des méthodes originales et de leurs grandes variantes utilisées en santé publique , 2008 .
[18] N. Dalkey,et al. An Experimental Application of the Delphi Method to the Use of Experts , 1963 .
[19] F. Rosendaal,et al. Increased fetal loss in women with heritable thrombophilia , 1996, The Lancet.
[20] R. Zotz,et al. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy. , 2003, Seminars in thrombosis and hemostasis.
[21] N Jairath,et al. The Delphi methodology (Part one): A useful administrative approach. , 1994, Canadian journal of nursing administration.
[22] J. Hirsh,et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[23] I. Greer,et al. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy , 2000, BJOG : an international journal of obstetrics and gynaecology.
[24] A. Kaider,et al. Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[25] P. Gibson,et al. Drugs in pregnancy. Anticoagulants. , 2001, Best practice & research. Clinical obstetrics & gynaecology.
[26] A. Eldor. The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy. , 2002, European journal of obstetrics, gynecology, and reproductive biology.
[27] L. Leape,et al. Measuring the Necessity of Medical Procedures , 1994, Medical care.
[28] S. Laporte,et al. Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women. , 2008, Thrombosis research.
[29] D. Spiegelhalter,et al. Consensus development methods, and their use in clinical guideline development. , 1998, Health technology assessment.
[30] B. Dahlbäck,et al. Individual risk assessment of thrombosis in pregnancy , 2002, Acta obstetricia et gynecologica Scandinavica.
[31] A. Kaider,et al. Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis , 2005, Journal of thrombosis and haemostasis : JTH.
[32] J. Bonnar,et al. Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? , 1999, American journal of obstetrics and gynecology.
[33] A. Pastuszak,et al. Drugs in pregnancy. , 1998, The New England journal of medicine.
[34] J. Langhoff‐Roos,et al. Inherited thrombophilias and adverse pregnancy outcome: screening and management. , 2005, Seminars in perinatology.
[35] J. Gris,et al. More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case‐control ‘NOHA First’ study , 2006, Journal of thrombosis and haemostasis : JTH.
[36] R H Brook,et al. A Method for the Detailed Assessment of the Appropriateness of Medical Technologies , 1986, International Journal of Technology Assessment in Health Care.
[37] P. Bernstein,et al. Risk factor scoring for predicting venous thromboembolism in obstetric patients , 2000 .
[38] C. Chauleur,et al. Enquête sur la prévention de la maladie thromboembolique maternelle après la publication des Recommandations pour la pratique clinique (RPC) , 2008 .
[39] A. James. Prevention and management of venous thromboembolism in pregnancy. , 2007, The American journal of medicine.
[40] J. Ray,et al. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. , 1999, Obstetrical & gynecological survey.
[41] Jeffrey S. Ginsberg,et al. Use of antithrombotic agents during pregnancy. , 1992, Chest.
[42] J. Hirsh,et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[43] G. Leone,et al. Prophylaxis and Treatment of Venous Thromboembolism in Individuals with Inherited Thrombophilia , 2006, Seminars in thrombosis and hemostasis.
[44] M. Spannagl,et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women , 2007, Thrombosis and Haemostasis.
[45] I. Greer. Prevention of venous thromboembolism in pregnancy. , 2003, European journal of medical research.
[46] C A Lindeman,et al. DELPHI SURVEY OF PRIORITIES IN CLINICAL NURSING RESEARCH , 1975, Nursing research.